Precision BioSciences Announces Publication of Cotton Trait Stacking Success in Collaboration with Bayer CropScience Herbicide Tolerance Gene Precisely Inserted Adjacent to Insect Resistance Gene using Site-Specific Genome Editing Technology Business Wire RESEARCH TRIANGLE PARK, N.C. -- November 26, 2012 Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that research, The Bayer Scientific Magazine, has published an article describing the successful use of Precision’s DNE technology to modify the genome of cotton. The article describes pioneering work performed by Kathleen D’Halluin and her colleagues at Bayer CropScience, who used an engineered DNE meganuclease produced by Precision to insert a gene into cotton. In doing so, D’Halluin was able to produce a “trait stack” in which two genes conferring valuable traits were targeted to the same location in the cotton genome. This is the first time that a gene editing approach, such as DNE, has been used successfully in cotton. Precision’s patent-protected technology provides plant researchers with exquisite control over a plant genome and offers enormous improvements in breeding efficiency. “We are enormously pleased with the results published by Bayer CropScience,” said Jeff Smith, Precision BioSciences’ Chief Scientific Officer. “Cotton is a notoriously difficult plant to manipulate and we expect DNE to play an important role in the genetic modification of such recalcitrant crop species.” “Precision’s long-standing focus on the development of the world's premier genome editing technology is continuing to pay off,” said Precision BioSciences CEO Matthew Kane. “We look forward to solving future unmet genome engineering challenges requiring the levels of precision that only DNE allows.” A link to the full pdf containing this article can be found at: http://www.research.bayer.com/en/straight-into-the-cotton-genome.aspx About Precision BioSciences Precision BioSciences’ mission is to continually provide, improve, and enable the world’s most powerful genome engineering technology. Precision’s proprietary Directed Nuclease Editor^TM (DNE) technology enables the production of genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or plant cells. Precision BioSciences’ vision is to be the conduit through which the world’s greatest genome engineering challenges are solved. Precision has successfully utilized its DNE technology to create innovative products in partnerships with many of the world’s largest biopharmaceutical, agbiotech, and animal research firms. Internally, Precision is developing applications of DNE in biological production and human therapeutics. For additional information, please visit www.precisionbiosciences.com. Contact: Precision BioSciences, Inc. Chelsea Lynam, +1 919-314-5512 email@example.com
Precision BioSciences Announces Publication of Cotton Trait Stacking Success in Collaboration with Bayer CropScience
Press spacebar to pause and continue. Press esc to stop.